COHERUS BIOSCIENCES INC (CHRS)
US19249H1032 - Common Stock
COHERUS BIOSCIENCES INC
NASDAQ:CHRS (12/4/2024, 2:05:48 PM)
1.82
+0.11 (+6.43%)
Company Profile
Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. The company is headquartered in Redwood City, California and currently employs 235 full-time employees. The company went IPO on 2014-11-06. The firm is focused on the research, development and commercialization of immunotherapies to treat cancer. The Company’s immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer. Casdozokitug is an IL-27 antagonistic antibody, which is being evaluated in two ongoing clinical studies: a Phase I/II study in advanced solid tumors and a Phase II study in hepatocellular carcinoma. CHS-114 is a highly selective, cytolytic anti-CCR8 antibody, which is in a Phase I study in patients with advanced solid tumors. CHS-1000 is a preclinical candidate targeting immune-suppressive mechanisms via the pathway ILT4. The company markets LOQTORZI (toripalimab-tpzi), a PD-1 inhibitor, and UDENYCA (pegfilgrastim-cbqv), a biosimilar of Neulasta.
Company Info
COHERUS BIOSCIENCES INC
C/O Dennis M. Lanfear, 201 Redwood Shores Parkway, Suite 200
Redwood City CALIFORNIA 94065
P: 16506493530
CEO: Dennis M. Lanfear
Employees: 246
Website: https://www.coherus.com/
CHRS News
a day ago - Market News VideoNoteworthy Tuesday Option Activity: CHRS, AVDL, BOX
a day ago - ChartmillCurious about the most active stocks on Tuesday? Find out which stocks are dominating the market action!Tuesday's session: most active stocks
a day ago - ChartmillHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.Let's have a look at the top gainers and losers in the middle of the day of today's session.
a day ago - ChartmillThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.Let's have a look at the gap up and gap down stocks in today's session.
a day ago - ChartmillWondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
a day ago - Coherus BioSciences, Inc.Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.CHRS Twits
Here you can normally see the latest stock twits on CHRS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
